Marketing Direct Mag - Spam Archive

Also in subscriptions.mhra.gov.uk

Speakers and programme confirmed for the joint BIA/MHRA regulatory conference

  Having trouble viewing this email? View it as a Web page.

The BioIndustry Association (BIA) and Medicines and Healthcare products Regulatory Agency (MHRA) are delighted to announce that registration is now open and the programme is available for the sixth joint regulatory conference on ‘Accelerated Development and Access to Innovative Medicines for Patients’ taking place on Wednesday 4 May 2016.

Register now

Programme confirmed

This one-day conference is an established fixture in the regulatory arena and offers attendees excellent value for money and is a must-attend event.

An impressive line-up of speakers are confirmed:

We are delighted to have Sir Hugh Taylor, Independent Chair, Accelerated Access Review and Professor Sir John Bell, Chair, Accelerated Access Review’s Expert Advisory Group providing keynote presentations.

Joining these keynote speakers will be senior experts and leading speakers from the MHRA, the European Medicines Agency (EMA), the life science industry, the NHS, NICE, investment firms and patient organisations including:

  • Dr Ian Hudson, Chief Executive, Medicines and Healthcare products Regulatory Agency
  • Alan Morrison, Chairman, BIA Regulatory Affairs Advisory Committee, and VP Regulatory Affairs International, MSD
  • Malcolm Qualie, Pharmacy Lead, Specialised Services, NHS England
  • Dr Nick Crabb, Programme Director, Scientific Affairs, National Institute for Health and Care Excellence (NICE)
  • Dr Eliot Forster, Chief Executive Officer, Immunocore
  • Robert Hemmings, Manager, Licensing Division, MHRA, and Chair, CHMP’s Scientific Advice Working Party, EMA
  • Jordi Llinares, Head of Product Development Scientific Support Department, EMA
  • Dr Joep Muijrers, Partner, LSP (Life Science Partners)

Plus many more. See who else is speaking here.


The conference is structured with a mix of presentations and engaging panel discussions on a wide-range of topics including:

  • Innovation and accelerated access in the UK – Where are we today?
  • The Early Access to Medicines Scheme (EAMS): Two years on
  • Adaptive pathways
  • The new EMA’s PRIME (Priority Medicines) scheme
  • Benefits of accelerated assessment in the EU
 
View the full programme and more details on the conference website and reserve your place today

Conference panel

Venue

Royal Society of Medicine
One Wimpole Street
London
W1G 0AE

Date

Wednesday 4 May 2016

Time

9.00 - 17.30

Register now

Fees

BIA Member: £395.00 + VAT
MHRA Contact: £395.00 + VAT
Non Member: £525.00 + VAT
Academic/NHS: £195.00 + VAT
Charity/NFP: £195.00 + VAT
Network Member: £195.00 + VAT

BIA Literature

 

 

 

© 2016 All content is available under the Open Government Licence v3.0, except where otherwise stated | .gov.uk email communications

Email gcs@cabinet-office.gsi.gov.uk | GCS - 020 7276 2295

Marketing Direct Mag - © Crown copyright | All printing supplied by PrintUK.com | Part of Spamdex - the spam archive for the internet

E-Marketing Madness

We have helpful advice from marketing experts across the globe, learn their tips and tricks and make your company more successful.